204 related articles for article (PubMed ID: 28073362)
1. Elevated levels of preβ1-high-density lipoprotein are associated with cholesterol ester transfer protein, the presence and severity of coronary artery disease.
Bu XM; Niu DM; Wu J; Yuan YL; Song JX; Wang JJ
Lipids Health Dis; 2017 Jan; 16(1):4. PubMed ID: 28073362
[TBL] [Abstract][Full Text] [Related]
2. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
3. Prebeta1-high-density lipoprotein (prebeta1-HDL) concentration can change with low-density lipoprotein-cholesterol (LDL-C) concentration independent of cholesteryl ester transfer protein (CETP).
Miida T; Ozaki K; Murakami T; Kashiwa T; Yamadera T; Tsuda T; Inano K; Okada M
Clin Chim Acta; 2000 Feb; 292(1-2):69-80. PubMed ID: 10686277
[TBL] [Abstract][Full Text] [Related]
4. Human serum preβ1-high density lipoprotein levels are independently and negatively associated with coronary artery diseases.
Chen Y; Dong J; Chen X; Jiang H; Bakillah A; Zhang X; Li Z; Yin J; Liang D; Zou Y; Hussain M; Cuchel M; Rader D; Chen H; Ge J; Jiang XC
Nutr Metab (Lond); 2016; 13():36. PubMed ID: 27190545
[TBL] [Abstract][Full Text] [Related]
5. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
[TBL] [Abstract][Full Text] [Related]
6. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
Takata M; Inazu A; Katsuda S; Miwa K; Kawashiri MA; Nohara A; Higashikata T; Kobayashi J; Mabuchi H; Yamagishi M
Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
[TBL] [Abstract][Full Text] [Related]
7. Influence of CETP on High-Density Lipoprotein Subclasses in Patients with Coronary Heart Disease.
Ding L; Jiang W; Chen Z; Zhang C; Tian Y; Long S
Clin Lab; 2020 Nov; 66(11):. PubMed ID: 33180445
[TBL] [Abstract][Full Text] [Related]
8. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
Kaman D; İlhan N; İlhan N; Akbulut M
Bosn J Basic Med Sci; 2015 Feb; 15(1):9-13. PubMed ID: 25725138
[TBL] [Abstract][Full Text] [Related]
9. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
Blankenberg S; Tiret L; Bickel C; Schlitt A; Jungmair W; Genth-Zotz S; Lubos E; Espinola-Klein C; Rupprecht HJ
Z Kardiol; 2004; 93 Suppl 4():IV16-23. PubMed ID: 15085362
[TBL] [Abstract][Full Text] [Related]
10. Probucol markedly reduces HDL phospholipids and elevated prebeta1-HDL without delayed conversion into alpha-migrating HDL: putative role of angiopoietin-like protein 3 in probucol-induced HDL remodeling.
Miida T; Seino U; Miyazaki O; Hanyu O; Hirayama S; Saito T; Ishikawa Y; Akamatsu S; Nakano T; Nakajima K; Okazaki M; Okada M
Atherosclerosis; 2008 Oct; 200(2):329-35. PubMed ID: 18279878
[TBL] [Abstract][Full Text] [Related]
11. Preβ1-High-Density Lipoprotein in Cardiovascular Diseases.
Chen Y; Dong J
Adv Exp Med Biol; 2020; 1276():189-195. PubMed ID: 32705601
[TBL] [Abstract][Full Text] [Related]
12. High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet.
Miida T; Yamaguchi T; Tsuda T; Okada M
Atherosclerosis; 1998 May; 138(1):129-34. PubMed ID: 9678778
[TBL] [Abstract][Full Text] [Related]
13. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
[TBL] [Abstract][Full Text] [Related]
14. Decreased cholesterol efflux capacity in patients with low cholesteryl ester transfer protein plasma levels.
Scharnagl H; Heuschneider C; Sailer S; Kleber ME; März W; Ritsch A
Eur J Clin Invest; 2014 Apr; 44(4):395-401. PubMed ID: 24467215
[TBL] [Abstract][Full Text] [Related]
15. Association between cholesteryl ester transfer protein TaqIB variants and risk of coronary artery disease and diabetes mellitus in the population of western Iran.
Rahimi Z; Nourozi-Rad R; Vaisi-Raygani A; Saidi MR; Rahimi Z; Ahmadi R; Yarani R; Hamzehee K; Parsian A
Genet Test Mol Biomarkers; 2011 Nov; 15(11):813-9. PubMed ID: 21689002
[TBL] [Abstract][Full Text] [Related]
16. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
van Acker BA; Botma GJ; Zwinderman AH; Kuivenhoven JA; Dallinga-Thie GM; Sijbrands EJ; Boer JM; Seidell JC; Jukema JW; Kastelein JJ; Jansen H; Verhoeven AJ;
Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
[TBL] [Abstract][Full Text] [Related]
17. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
Schierer A; Been LF; Ralhan S; Wander GS; Aston CE; Sanghera DK
Pharmacogenet Genomics; 2012 Feb; 22(2):95-104. PubMed ID: 22143414
[TBL] [Abstract][Full Text] [Related]
18. Alterations in lipid transfers to HDL associated with the presence of coronary artery disease in patients with type 2 diabetes mellitus.
Sprandel MC; Hueb WA; Segre A; Ramires JA; Kalil-Filho R; Maranhão RC
Cardiovasc Diabetol; 2015 Aug; 14():107. PubMed ID: 26268997
[TBL] [Abstract][Full Text] [Related]
19. Increasing high-density lipoprotein cholesterol, inhibition of cholesteryl ester transfer protein, and heart disease risk reduction.
Schaefer EJ; Asztalos BF
Am J Cardiol; 2007 Dec; 100(11 A):n25-31. PubMed ID: 18047849
[TBL] [Abstract][Full Text] [Related]
20. The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.
Tian L; Li C; Liu Y; Chen Y; Fu M
PLoS One; 2014; 9(1):e85114. PubMed ID: 24465490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
